* OPEC+ may roll over output levels for April, sources say* U.S. expects vaccines for all adults by end of May* U.S. crude stocks rose unexpectedly last week (Updates with...
By Carl O'Donnell and Jarrett Renshaw NEW YORK (Reuters) - U.S. states need to "rally together" to maintain safety measures like social distancing and mask-wearing while the...
According to Dr. Muriel Jean-Jacques, assistant professor of medicine at Northwestern University, Johnson & Johnson’s newly approved vaccine has two game-changing qualities.It's...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Sell | Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 26.79 | 27.67 | 26.40 | -0.50 | -1.83% | 2.07M | Toronto | |||
| 31.62 | 35.50 | 31.35 | -5.37 | -14.52% | 113.12K | TSXV | |||
| 137.00 | 140.01 | 129.03 | -26.16 | -16.03% | 554.36K | Toronto | |||
| 21.85 | 23.25 | 21.18 | -1.160 | -5.04% | 1.86M | Toronto | |||
| 2.98 | 3.00 | 2.54 | +0.690 | +30.13% | 17.50K | TSXV | |||
| 1.00 | 1.02 | 1.00 | +0.01 | +1.01% | 202.20K | CSE | |||
| 0.72 | 0.00 | 0.00 | -0.0750 | -9.43% | 2.81M | TSXV | |||
| 2.42 | 2.74 | 2.33 | -0.3200 | -11.68% | 1.57M | TSXV | |||
| 20.29 | 21.91 | 19.60 | -0.94 | -4.43% | 641.53K | Toronto | |||
| 50.05 | 50.06 | 49.51 | +0.34 | +0.68% | 509.91K | Toronto | |||
| 3.93 | 3.97 | 3.93 | -0.02 | -0.51% | 47.03K | Toronto | |||
| 56.05 | 56.08 | 55.47 | +0.48 | +0.86% | 853.40K | Toronto | |||
| 4.74 | 5.37 | 4.61 | -0.7000 | -12.87% | 1.84M | TSXV | |||
| 26.18 | 26.18 | 25.85 | +0.12 | +0.46% | 674.76K | Toronto | |||
| 0.12 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00K | CSE |
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.